ArticleMolecular cancer therapeutics2015

Cosilencing of PKM-2 and MDR-1 Sensitizes Multidrug-Resistant Ovarian Cancer Cells to Paclitaxel in a Murine Model of Ovarian Cancer.

Meghna Talekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.